PerkinElmer : J.P. Morgan 41st Healthcare Conference Presentation

J.P. MORGAN

41st Healthcare Conference

Prahlad Singh

Chief Executive Officer

January 10, 2023

SAFE HARBOR

This presentation contains "forward-looking" statements which are statements relating to future events. These statements include those relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. A detailed description of these risk factors can be found under the caption "Risk Factors" in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this presentation.

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this presentation also contains non-GAAP financial measures. A reconciliation of these measures to the most directly comparable GAAP measures is included in the embedded hyperlinkand is available on the "Investor Events" section of our investor relations website at ir.perkinelmer.com.

Guidance for future periods is provided on a non-GAAP basis and cannot be reconciled to the closest GAAP measures without unreasonable effort due to the unpredictability of the amounts and timing of events affecting the items the Company excludes from these non-GAAP measures. The timing and amounts of such events and items could be material to the Company's results prepared in accordance with GAAP.

2

LOOKING BACK TO 2020…

From Our 2020 JP Morgan Presentation:

3

…WE HAVE DELIVERED ON THIS STRATEGIC FOCUS

From Our 2020 JP Morgan Presentation:

4

Announced Sale of

Applied and

Enterprise

Solutions

Business and Brand to New Mountain Capital for up to $2.45 Billion

Divestiture expected

to close in 1Q23

2019 2021

% of	~60%	~80%
Revenue	LS & Dx	LS & Dx

INCREASED	ACCELERATED
FOCUS ON	INNOVATION AND
LIFE SCIENCES	CAPITAL
AND DIAGNOSTICS	DEPLOYMENT

2023

FASTER GROWTH, HIGHER MARGINS, AND STRONG RECURRING REVENUES

5